These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26756902)

  • 21. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
    Hofvind S; Sagstad S; Sebuødegård S; Chen Y; Roman M; Lee CI
    Radiology; 2018 Apr; 287(1):58-67. PubMed ID: 29239711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
    Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
    JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
    O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
    Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
    Sawada T; Akashi S; Nakamura S; Kuwayama T; Enokido K; Yoshida M; Hashimoto R; Ide T; Masuda H; Taruno K; Oyama H; Takamaru T; Kanada Y; Ikeda M; Kosugi N; Sato H; Nakayama S; Ata A; Tonouchi Y; Sakai H; Matsunaga Y; Matsutani A
    Breast Cancer; 2017 Sep; 24(5):708-713. PubMed ID: 28238177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
    Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
    J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.
    Taplin SH; Abraham L; Geller BM; Yankaskas BC; Buist DS; Smith-Bindman R; Lehman C; Weaver D; Carney PA; Barlow WE
    J Natl Cancer Inst; 2010 Jul; 102(14):1040-51. PubMed ID: 20601590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
    Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
    JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are there racial/ethnic disparities among women younger than 40 undergoing mammography?
    Kapp JM; Walker R; Haneuse S; Buist DS; Yankaskas BC
    Breast Cancer Res Treat; 2010 Nov; 124(1):213-22. PubMed ID: 20204501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors Impacting False Positive Recall in Screening Mammography.
    Honig EL; Mullen LA; Amir T; Alvin MD; Jones MK; Ambinder EB; Falomo ET; Harvey SC
    Acad Radiol; 2019 Nov; 26(11):1505-1512. PubMed ID: 30772138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
    Fujii MH; Herschorn SD; Sowden M; Hotaling EL; Vacek PM; Weaver DL; Sprague BL
    AJR Am J Roentgenol; 2019 Mar; 212(3):706-711. PubMed ID: 30673339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of first mammography examination in women younger than 40 years.
    Yankaskas BC; Haneuse S; Kapp JM; Kerlikowske K; Geller B; Buist DS;
    J Natl Cancer Inst; 2010 May; 102(10):692-701. PubMed ID: 20439838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
    Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
    JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
    JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
    van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
    Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.
    Domingo L; Romero A; Blanch J; Salas D; Sánchez M; Rodríguez-Arana A; Ferrer J; Ibáñez J; Vega A; Laso MS; Castells X; Sala M
    Cancer Epidemiol; 2013 Oct; 37(5):660-5. PubMed ID: 23962702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for breast cancer: an update for the U.S. Preventive Services Task Force.
    Nelson HD; Tyne K; Naik A; Bougatsos C; Chan BK; Humphrey L;
    Ann Intern Med; 2009 Nov; 151(10):727-37, W237-42. PubMed ID: 19920273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
    Kuhl CK; Keulers A; Strobel K; Schneider H; Gaisa N; Schrading S
    Breast Cancer Res; 2018 Feb; 20(1):13. PubMed ID: 29426360
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.